Relation between vitamin D3 and the peripheral circulation in moderate arterial essential hypertension

[1]  J. De Sutter,et al.  Peripheral vascular changes and ambulatory blood pressure profiles. , 1993, American journal of hypertension.

[2]  D. McCarron,et al.  Urinary calcium excretion in essential hypertension. , 1992, The Journal of laboratory and clinical medicine.

[3]  D. DiPette,et al.  Systemic and regional hemodynamic effects of 1,25-dihydroxyvitamin D3 administration. , 1992, Journal of hypertension.

[4]  T. Saruta,et al.  Disturbed calcium metabolism in offspring of hypertensive parents. , 1992, Hypertension.

[5]  J. Kaufman,et al.  Influence of the arterial blood pressure and nonhemodynamic factors on left ventricular hypertrophy in moderate essential hypertension. , 1991, The American journal of cardiology.

[6]  R. Bukoski,et al.  Injection of 1,25-(OH)2 vitamin D3 enhances resistance artery contractile properties. , 1990, Hypertension.

[7]  R. Simpson,et al.  The involvement of the endocrine system in regulating cardiovascular function: emphasis on vitamin D3. , 1989, Endocrine reviews.

[8]  M. Haussler,et al.  Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. , 1989, The Journal of clinical investigation.

[9]  H. Koeffler,et al.  The role of the vitamin D endocrine system in health and disease. , 1989, The New England journal of medicine.

[10]  L. Lind,et al.  Hypertension in primary hyperparathyroidism--reduction of blood pressure by long-term treatment with vitamin D (alphacalcidol). A double-blind, placebo-controlled study. , 1988, American journal of hypertension.

[11]  S. Epstein,et al.  Normal vitamin D and mineral metabolism in essential hypertension. , 1988, The American journal of the medical sciences.

[12]  K. Wegscheider,et al.  Functional versus structural changes of forearm vascular resistance in hypertension. , 1988, Hypertension.

[13]  A. Hofman,et al.  Raised plasma intact parathyroid hormone concentrations in young people with mildly raised blood pressure , 1988, British medical journal.

[14]  McCarron Da.  Ca2+, vitamin D, parathyroid hormone, and blood pressure: why should it matter? , 1987 .

[15]  M. Safar,et al.  Structural and functional modifications of peripheral large arteries in hypertensive patients. , 1987, Journal of clinical hypertension.

[16]  E. Roccella,et al.  Epidemiologic considerations in defining hypertension. , 1987, The Medical clinics of North America.

[17]  R. Bergström,et al.  Relationships Between Calcium Metabolic Indices and Blood Pressure in Patients with Essential Hypertension as Compared with a Healthy Population , 1987, Journal of hypertension.

[18]  D. Clement,et al.  Regional Circulation Through Finger and Calf Arteries in Essential Hypertension , 1987 .

[19]  M. Walters,et al.  1,25-Dihydroxyvitamin D3 receptors identified in the rat heart. , 1986, Journal of molecular and cellular cardiology.

[20]  U. Gafter,et al.  Evidence against the role of calcium deficiency in genetic hypertension. , 1986, Hypertension.

[21]  A. D. De leenheer,et al.  Radioimmunoassay for 1,25-dihydroxyvitamin D in serum or plasma. , 1985, Clinical chemistry.

[22]  I. Holmberg,et al.  Determination of 25-hydroxyvitamin D3 in serum by high performance liquid chromatography and isotope dilution-mass spectrometry. , 1984, Scandinavian journal of clinical and laboratory investigation.

[23]  M. Cirillo,et al.  Abnormalities of calcium metabolism in essential hypertension. , 1983, Clinical science.

[24]  D. Clement,et al.  Reactive Hyperemia in Patients With Intermittent Claudication, and Correlation With Other Diagnostic Methods , 1980, Angiology.

[25]  R. Rubin,et al.  Enhanced Parathyroid Function in Essential Hypertension A Homeostatic Response to a Urinary Calcium Leak , 1980, Hypertension.